ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SBTX Skinbiotherapeutics Plc

9.25
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.00 9.50 9.25 9.25 9.25 206,658 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M

SkinBioTherapeutics PLC Holding(s) in Company (4221S)

16/03/2021 6:52pm

UK Regulatory


TIDMSBTX

RNS Number : 4221S

SkinBioTherapeutics PLC

16 March 2021

TR-1: S tandard form for notification of major holdings

 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
 to the FCA in Microsoft Word format if possible) (i) 
 
1a. Identity of the issuer or the                         SkinBioTherapeutics plc 
 underlying issuer of existing shares 
 to which voting rights are attached                       Company No: 09632164 (England) 
 (ii) : 
1b. Please indicate if the issuer is a non-UK issuer (please mark with 
 an "X" if appropriate) 
Non-UK issuer 
2. Reason for the notification (please mark the appropriate box or boxes 
 with an "X") 
An acquisition or disposal of voting rights                                                     x 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights 
Other (please specify)(iii) : 
3. Details of person subject to the notification obligation (iv) 
Name                                                      Seneca Partners Limited 
City and country of registered office                     Haydock, Greater Manchester UK 
 (if applicable) 
4. Full name of shareholder(s) (if different from 3.) (v) 
Name                                                      Share Nominees Limited, WCS Nominees 
                                                           Limited, Platform Securities Nominees 
                                                           Limited. 
City and country of registered office                     Aylesbury, Bucks, UK, London UK 
 (if applicable) 
5. Date on which the threshold was                        12/03/2021 
 crossed or reached (vi) : 
6. Date on which issuer notified (DD/MM/YYYY):            16/03/2021 
7. Total positions of person(s) subject to the notification obligation 
                         % of voting        % of voting rights     Total of both  Total number 
                          rights attached    through financial      in % (8.A +    of voting rights 
                          to shares (total   instruments            8.B)           of issuer (vii) 
                          of 8. A)           (total of 8.B 
                                             1 + 8.B 2) 
Resulting situation 
 on the date 
 on which threshold 
 was crossed 
 or reached              10.4                                      10.4           155,889,922 
Position of 
 previous notification 
 (if 
 applicable)             11.8                                      11.8 
 
 
 
8. Notified details of the resulting situation on the date on which the 
 threshold was crossed or reached (viii) 
A: Voting rights attached to shares 
Class/type of       Number of voting rights (ix)                           % of voting rights 
 shares 
 ISIN code (if 
 possible) 
                    Direct                    Indirect                     Direct                       Indirect 
                     (Art 9 of Directive       (Art 10 of Directive         (Art 9 of Directive          (Art 10 of Directive 
                     2004/109/EC)              2004/109/EC)                 2004/109/EC) (DTR5.1)        2004/109/EC) 
                     (DTR5.1)                  (DTR5.2.1)                                                (DTR5.2.1) 
Ordinary Shares 
 
 GB00BF33H870                16,255,710       N/A                          10.4                         N/A 
 
 
 
SUBTOTAL 8. A                 16,255,710                                   10.4 
 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
 (DTR5.3.1.1 (a)) 
Type of financial   Expiration      Exercise/                      Number of voting                     % of voting 
 instrument          date (x)        Conversion Period              rights that may                      rights 
                                     (xi)                           be acquired if the 
                                                                    instrument is 
                                                                    exercised/converted. 
 
 
 
                                    SUBTOTAL 8. B 1 
 
B 2: Financial Instruments with similar economic effect according to Art. 
 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
Type of      Expiration             Exercise/             Physical or              Number of            % of voting 
 financial    date (x)               Conversion            cash                     voting rights        rights 
 instrument                          Period (xi)           settlement 
                                                           (xii) 
 
 
 
                                                          SUBTOTAL 8.B.2 
 
9. Information in relation to the person subject to the notification 
 obligation (please mark the 
 applicable box with an "X") 
Person subject to the notification obligation is not controlled                                                      x 
 by any natural person or legal entity and does not control any other 
 undertaking(s) holding directly or indirectly an interest in the 
 (underlying) issuer (xiii) 
Full chain of controlled undertakings through which the voting rights 
 and/or the 
 financial instruments are effectively held starting with the ultimate 
 controlling natural person or legal entity (xiv) (please add additional 
 rows as necessary) 
Name (xv)                 % of voting rights              % of voting rights                 Total of both if 
                           if it equals or                 through financial                  it equals or is 
                           is higher than the              instruments if it                  higher than the 
                           notifiable threshold            equals or is higher                notifiable threshold 
                                                           than the notifiable 
                                                           threshold 
 
 
 
 
 
 
10. In case of proxy voting, please identify: 
Name of the proxy holder 
The number and % of voting rights 
 held 
The date until which the voting rights 
 will be held 
 
11. Additional information (xvi) 
 
 
 
 
Place of completion  Haydock, Greater Manchester UK 
Date of completion   16 March 2021 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLJFMMTMTIBBLB

(END) Dow Jones Newswires

March 16, 2021 14:52 ET (18:52 GMT)

1 Year Skinbiotherapeutics Chart

1 Year Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart

Your Recent History

Delayed Upgrade Clock